Related Experiment Videos
[Variability of human immunodeficiency virus type 1]
F Brun-Vézinet1, F Damond, F Simon
1Laboratoire de virologie, Hôpital Bichat-Claude Bernard, Paris, France.
Bulletin De La Societe De Pathologie Exotique (1990)
|November 26, 1999
Summary
Human immunodeficiency virus type 1 (HIV-1) exhibits high variability, with distinct subtypes influencing vaccine development and HIV diagnosis. Understanding these subtypes is crucial for effective global health strategies.
Area of Science:
- Virology
- Genetics
- Epidemiology
Background:
- Human immunodeficiency virus type 1 (HIV-1) displays significant genetic diversity, with at least three distinct lineages (HIV-1 group M, HIV-1 group O, and HIV-2) identified, indicating multiple zoonotic origins.
- HIV-1 group M is the primary cause of the global AIDS epidemic, characterized by at least ten identified subtypes (A-J).
Purpose of the Study:
- To detail the genetic variability and classification of HIV-1 subtypes.
- To highlight the implications of HIV-1 diversity on vaccine development and diagnostic accuracy.
Main Methods:
- Subtyping of HIV-1 group M relies on analyzing viral sequences, specifically from the gag and env genes.
- The V3 region of the gp 120 env gene is a key area for differentiating HIV-1 group M subtypes.
Main Results:
- Significant nucleotide divergence (average 30% for the env gene) exists between different HIV-1 subtypes.
- Geographical distribution varies among subtypes, with some identified as recombinant or mosaic viruses.
Conclusions:
- The genetic diversity of HIV-1 poses challenges for developing effective vaccines.
- Variations in HIV-1 subtypes may impact the accuracy of diagnostic tests.
- Further research is needed to determine if HIV-1 subtypes differ in transmissibility or pathogenicity.